SAFE Sunscreen Standards Act

LEGISLATIVE PROGRESS

STEP 2 OF 8

Introduced

In Committee

Reported

Passed Senate

Passed House

Conference

To President

Became Law

Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law

WHAT THE BILL DOES

AI-written

This bill matters to voters because it directly impacts the availability and innovation of products many Americans use daily, like sunscreen. For years, there have been concerns that the FDA's current review process for sunscreen ingredients is too slow, leading to a limited selection of active ingredients compared to other countries. This delay can hinder access to potentially more effective or cosmetically appealing sunscreens.

If this bill becomes law, it could accelerate the approval process for new sunscreen ingredients and other skin-applied drugs by allowing the FDA to consider more diverse types of scientific evidence and encouraging alternatives to animal testing. This could lead to a wider range of sunscreens on store shelves, potentially improving public health by offering more choices for skin cancer prevention. If it doesn't pass, the current, slower review process would likely continue, potentially delaying access to new ingredients and maintaining existing animal testing requirements.

KEY PROVISIONS

AI-extracted

high

The FDA must allow the use of 'real world evidence,' alongside traditional clinical trials, to evaluate the safety and effectiveness of active ingredients in nonprescription topical drugs.

This could speed up the approval of new ingredients for products like sunscreens by expanding the types of data the FDA can consider.

high

The FDA must consider alternatives to animal testing for nonclinical tests of topical drug ingredients and issue guidance on how companies can use these methods.

This promotes more ethical and potentially faster testing methods, reducing reliance on animal experiments.

high

When issuing its final rule for sunscreen active ingredients, the FDA must consider historical data on ingredients already marketed in the U.S. and the importance of broad-spectrum sunscreens (SPF 15+) in preventing skin cancer.

This ensures the FDA's decision-making on sunscreens acknowledges existing knowledge and their crucial public health role.

med

The FDA must report annually for five years to Congress on the implementation of these new evidence standards and progress on non-animal testing alternatives for topical drugs.

This provides transparency and accountability, allowing Congress and the public to track the FDA's progress.

DEADLINES & DATES

AI-extracted

An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)

Not later than 1 year after the date of enactment

Issue new draft guidance on how sponsors can use nonclinical testing alternatives to animal testing for drugs intended for topical administration.

Not later than 18 months after the date of enactment

Submit the first report to Congress describing the status of implementing new evidence/testing standards and progress on non-animal testing.

Annually for 5 years after the first report

Submit annual reports to Congress for 5 years describing the status of implementing new evidence/testing standards and progress on non-animal testing.

Not later than 7 days after the date on which the report is submitted

Publish each report submitted to Congress on the FDA website.

GLOSSARY

AI-written

Federal Food, Drug, and Cosmetic Act: The main law that gives the FDA authority to regulate food, drugs, cosmetics, and medical devices in the United States.
Nonprescription drugs: Medicines that can be bought without a doctor's prescription, often called over-the-counter drugs.
Topical administration: When a drug is applied to a particular place on or in the body, such as the skin, to treat a local condition.
Active ingredients: The component in a drug that provides the intended medicinal effect.
Real world evidence: Clinical evidence about a drug's use and potential benefits or risks derived from data gathered outside of traditional clinical trials, such as from electronic health records, claims data, or patient registries.
Nonclinical tests: Tests performed on a drug, often in a lab setting or using computational models, before it is tested in humans.
Sun Protection Factor (SPF): A measure of how well a sunscreen protects skin from ultraviolet B (UVB) rays, which cause sunburn and contribute to skin cancer.

ACTION TIMELINE

2 EVENTS

JUL 29, 25

Introduced in Senate

INTROREFERRAL

JUL 29, 25

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

INTROREFERRAL

READER REACTIONS

0 COMMENTS

WHAT DO YOU THINK?

What do you think?

0 votes

Discussion

Loading comments...

MORE INFORMATION

Committee Referrals

Health, Education, Labor, and Pensions CommitteeReferred

Jul 29, 2025

senate

SAFE Sunscreen Standards Act

LEGISLATIVE PROGRESS

WHAT THE BILL DOES

KEY PROVISIONS

SPONSORSHIP

ACTION TIMELINE

BILL INFO

READER REACTIONS

Discussion

SAFE Sunscreen Standards Act

LEGISLATIVE PROGRESS

WHAT THE BILL DOES

KEY PROVISIONS

DEADLINES & DATES

GLOSSARY

ACTION TIMELINE

SPONSORS

READER REACTIONS

What do you think?

Discussion

MORE INFORMATION

Committee Referrals

Search

SAFE Sunscreen Standards Act

LEGISLATIVE PROGRESS

WHAT THE BILL DOES

KEY PROVISIONS

SPONSORSHIP

ACTION TIMELINE

BILL INFO

READER REACTIONS

Discussion

SAFE Sunscreen Standards Act

LEGISLATIVE PROGRESS

WHAT THE BILL DOES

KEY PROVISIONS

DEADLINES & DATES

GLOSSARY

ACTION TIMELINE

SPONSORS

READER REACTIONS

What do you think?

Discussion

MORE INFORMATION

Committee Referrals